Quillin Highlights Arthrex Decision as Key Patent Ruling of 2021 for Law360
July 6, 2021
Law360
Partner George E. Quillin was quoted in Law360’s first half recap of the key patent rulings and decisions in 2021, “The Biggest Patent Rulings Of 2021: A Midyear Report,” highlighting the importance of the high court’s ruling on the Patent Trial and Appeal Board process.
On the significance of U.S. vs. Arthrex decision, George said, “The court’s remedy requires only that the director have the discretion to decide whether or not he will rehear any of the IPRs. The cynic can imagine a busy bureaucrat’s easy choice on such a decision.”
People
Related News
June 26, 2025
In the News
Alejandro Gomez-Strozzi on Mexico-US Auto Parts Trade – 'Going forward, there is nothing but integration'
Foley & Lardner lLP partner Alejandro Gómez-Strozzi shared insights on foreign direct investment around Mexico's automotive parts sector in the El Economista article, "Efecto Trump pega más a IED en autopartes que en autos y camiones."
June 25, 2025
In the News
Jocelyn Lavallo Explores Nuclear's Emerging Role in Project Finance
Foley & Lardner LLP partner Jocelyn Lavallo examined the increasing relevance of advanced nuclear technologies in the evolving clean energy landscape in her Environment+Energy Leader article, "Nuclear’s Emerging Role in Project Finance: A Cross-Technology Perspective."
June 25, 2025
In the News
Kyle Faget Comments on AI, User Fees Ahead of MDUFA Negotiations
Foley & Lardner LLP partner Kyle Faget weighed in on the role of user fees and artificial intelligence as stakeholders prepare for the next Medical Device User Fee Amendments (MDUFA) reauthorization in the Medtech Insight article, "Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?"